Clinical Trial

To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants

Study acronym: PHEGI
Completed
View on ClinicalTrials.gov →
Summary
This is an Open-Label, Randomized, Three-Way, Three-Arm, Crossover, Balance Study to Evaluate the Effect of Phaseolean on Glycemic response to carbohydrate rich meals in Healthy Adult Participants Using an In Vivo Method.
Protocol Amendment History 1 change
critical Completed without a posted recruiting period 2026-08-07
Trial Details
NCT Number NCT07466667
Lead Sponsor NovoBliss Research Pvt Ltd
Collaborators: Ambe Phytoextracts Pvt. Ltd
Conditions Healthy
Enrollment 12 participants
Start Date 2026-03-19
Primary Completion 2026-04-29 (estimated)
Study Completion 2026-04-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-06